GLUCURONIDATED ACETAMINOPHEN AS MARKER OF LIVER DISORDERS Russian patent published in 2015 - IPC G01N33/94 

Abstract RU 2555331 C2

FIELD: medicine.

SUBSTANCE: claimed invention relates to a method of diagnosing liver disorders in people, such as nonalcoholic steatohepatitis (NASH) and liver fibrosis, as well as to a machine-readable carrier, containing a set of instructions for control of a device for measuring metabolites in order to realise diagnostics. The diagnostics is carried out by the determination of acetaminophen (APAP)-glucoronide in a plasma sample and/or urine sample, obtained from a human subject after the introduction of acetaminophen (APAP) to the human subject, where the subject has a risk of the liver disorder; comparison of the obtained quantity of (APAP)-glucoronide with the control; identification of the subject as suffering from NASH or liver fibrosis in case of increased levels of APAP-glucoronide in one or both plasma samples and urine samples in comparison with the control.

EFFECT: improvement of diagnostics.

8 cl, 1 tbl, 5 ex, 6 dwg

Similar patents RU2555331C2

Title Year Author Number
VAP-1 INHIBITORS ADMINISTRATION FOR FIBROID DISEASES TREATMENT 2010
  • Veston, Kristofer
  • Klaridzh, Li Charlz
  • Adams, Devid
  • Smit, Devid
  • Vesterlund, Nina
  • Pikhlavisto, Maro
  • Esterman, Tua
RU2667963C1
METHOD OF TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) WITH USING CYSTEAMINE PRODUCTS 2008
  • Dokhil Randzhan
  • Shnajder Dzherri
RU2498795C2
USE OF VAP-1 INHIBITORS FOR FIBROTIC SICKNESS TREATMENT 2010
  • Veston Kristofer
  • Klaridzh Li Charlz
  • Adams Devid
  • Smit Devid
  • Vesterlund Nina
  • Pikhlavisto Maro
  • Esterman Tua
RU2580626C2
THERAPEUTIC AGENT FOR LIVER DISEASES 2018
  • Moon, Sung Hwan
  • Lee, Soo Jin
  • Lee, Sung Chan
  • Bae, Yun Soo
RU2723686C1
MATERIALS AND METHODS OF TREATING CHRONIC FIBROUS DISEASES 2006
  • Khogaboum Kori M.
  • Kunkel' Stiven L.
RU2446825C2
COMPOSITION AND USE OF ARGININE-DEPLETING AGENTS IN CANCER, OBESITY, METABOLIC DISORDERS AND RELATED COMPLICATIONS AND COMORBIDITIES 2019
  • Leng, Yun Chun
  • Shum, Alisa Sau-Vun
RU2826185C2
UNORDERED PEPTIDE LIBRARY, METHOD OF PREPARATION THEREOF, AND METHOD OF IDENTIFYING PEPTIDE PREPARED BY SOLID-PHASE SYNTHESIS 1991
  • Kit Sang Lehm
RU2145233C1
METHOD FOR DETERMINING THE PROBABILITY OF HEPATIC FIBROSIS IN PATIENTS PREVIOUSLY SUFFERING FROM COVID-19 2021
  • Kruchinina Margarita Vitalevna
  • Svetlova Irina Olegovna
  • Gromov Andrej Aleksandrovich
  • Logvinenko Irina Ivanovna
  • Belkovets Anna Vladimirovna
  • Kashtanova Elena Vladimirovna
  • Shramko Viktoriya Sergeevna
  • Pushkina Olga Viktorovna
RU2764050C1
COMPOSITIONS AND METHODS FOR PAIN RELIEF 2018
  • Bazan Nikolas
  • Bazan Ernan
  • Alvares-Bujlya Khulio
  • Pol Dennis
  • Burgos Karolina
RU2777368C2
COMBINATION OF OMEGA-3 FATTY ACID AND SGLT-2 INHIBITOR FOR TREATING LIVER DISEASES 2015
  • Gannedahl Karl Erik Goeran
RU2695652C2

RU 2 555 331 C2

Authors

Cherrington Natan

Dates

2015-07-10Published

2009-09-30Filed